Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization

被引:12
|
作者
Rathmann, Nils [1 ]
Kara, Kerim [2 ]
Budjan, Johannes [1 ]
Henzler, Thomas [1 ]
Smakic, Arman [1 ]
Schoenberg, Stefan O. [1 ]
Diehl, Steffen J. [1 ]
机构
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Inst Clin Radiol & Nucl Med, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany
[2] Heidelberg Univ, Med Fac Mannheim, Fraunhofer Project Grp Automat Med & Biotechnol, Mannheim, Germany
关键词
PLBV; DEB TACE; HCC; cone beam CT; COMPUTED-TOMOGRAPHY; TUMOR RESPONSE; PREDICTION;
D O I
10.21873/anticanres.12004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Prospective comparison of cone beam C-Arm CT based parenchymal liver blood volume (PLBV) and dynamic volume perfusion CT (dVPCT) measurements in patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolisation (TACE) with drug-eluting beads (DEB). Patients and Methods: In 16 patients, changes of PLBV and dVPCT measurements [ arterial liver parenchyma (ALP); temporal maximum intensity projection (MIP); hepatic perfusion index (HPI); portal venous parenchyma] were correlated to one another and to the modified Response Evaluation Criteria in Solid Tumors (mRECIST). Results: After TACE, the following parameters showed a statistically significant change (p< 0.05) in mean value: PLBV: -4.85 ml/100 ml, ALP: -4.14 ml/100 ml/min, MIP: -0.23 Houndsfield units, HPI: -5.39%, and mRECIST: -20.53 mm. Pre-to-post TACE differences in PLBV showed only weak to very weak correlation to dVPCT parameters (r(2)< 0.24). Conclusion: Although PLBV and dVPCT parameters showed only a weak to very weak correlation, both methods validly assessed changes in arterial tumor vascularity after DEB TACE.
引用
收藏
页码:5681 / 5685
页数:5
相关论文
共 50 条
  • [41] Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report
    Kaufmann, Sascha
    Schulze, Maximilian
    Spira, Daniel
    Horger, Marius
    ACTA RADIOLOGICA, 2016, 57 (01) : 8 - 12
  • [42] Prognostic factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization and radioembolization: a retrospective study
    Jeliazkova, Petia
    Umgelter, Andreas
    Braren, Rickmer
    Kaissis, Georgios
    Mustafa, Mona
    Einwaechter, Henrik
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (08) : 1036 - 1041
  • [43] Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Megan E. McNally
    Antonio Martinez
    Hooman Khabiri
    Gregory Guy
    Anthony J. Michaels
    James Hanje
    Robert Kirkpatrick
    Mark Bloomston
    Carl R. Schmidt
    Annals of Surgical Oncology, 2013, 20 : 923 - 928
  • [44] Prognostic value of preoperative serum ferritin in hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Fan, Mi
    Niu, Tingting
    Lin, Binwei
    Gao, Feng
    Tan, Bangxian
    Du, Xiaobo
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (03)
  • [45] Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Jung, Eun Suk
    Kim, Ji Hoon
    Yoon, Eileen L.
    Lee, Hyun Jung
    Lee, Soon Jae
    Suh, Sang Jun
    Lee, Beom Jae
    Seo, Yeon Seok
    Yim, Hyung Joon
    Seo, Tae-Seok
    Lee, Chang Hee
    Yeon, Jong Eun
    Park, Jong-Jae
    Kim, Jae Seon
    Bak, Young Tae
    Byun, Kwan Soo
    JOURNAL OF HEPATOLOGY, 2013, 58 (06) : 1181 - 1187
  • [46] Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    McNally, Megan E.
    Martinez, Antonio
    Khabiri, Hooman
    Guy, Gregory
    Michaels, Anthony J.
    Hanje, James
    Kirkpatrick, Robert
    Bloomston, Mark
    Schmidt, Carl R.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (03) : 923 - 928
  • [47] Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index
    Mueller, Lukas
    Hahn, Felix
    Maehringer-Kunz, Aline
    Stoehr, Fabian
    Gairing, Simon Johannes
    Michel, Maurice
    Foerster, Friedrich
    Weinmann, Arndt
    Galle, Peter Robert
    Mittler, Jens
    Pinto dos Santos, Daniel
    Pitton, Michael Bernhard
    Dueber, Christoph
    Kloeckner, Roman
    CANCERS, 2021, 13 (19)
  • [48] Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Espejo-Cruz, Maria L.
    Gonzalez-Rubio, Sandra
    Espejo, Juan J. J.
    Zamora-Olaya, Javier M. M.
    Alejandre-Altamirano, Rafael M. M.
    Prieto-Torre, Maria
    Linares, Clara I. I.
    Guerrero-Misas, Marta
    Barrera-Baena, Pilar
    Poyato-Gonzalez, Antonio
    Sanchez-Frias, Marina
    Ayllon, Maria D.
    Rodriguez-Peralvarez, Manuel L. L.
    de la Mata, Manuel
    Ferrin, Gustavo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [49] Reply to comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Cho, Yun Ku
    CANCER, 2008, 112 (12) : 2821 - 2821
  • [50] EFFECT OF ACUTE KIDNEY INJURY ON THE PROGNOSIS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING TRANSARTERIAL CHEMOEMBOLIZATION
    Sohn, Won
    Ham, Cheol Bae
    Kim, Nam Hee
    Kim, Hong Joo
    Cho, Yong Kyun
    Kim, Byung Ik
    HEPATOLOGY, 2019, 70 : 226A - 226A